What's Going On With Exascale Labs Stock Monday?
Exascale Labs (NASDAQ: XLAB) trades up 27% premarket. Read about its 111% revenue growth, AI compute deals, and fiscal 2027 outlook.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Exascale Labs (NASDAQ: XLAB) trades up 27% premarket. Read about its 111% revenue growth, AI compute deals, and fiscal 2027 outlook.
On October 9, 2026, Exascale Labs Holdings Inc. (NASDAQ:XLAB, XLABW))), a Delaware corporation (the "Company"), entered into a purchase and sale agreement dated as of October 8, 2026 (the "PSA") with the
Exascale Labs Holdings (NASDAQ:XLAB) reported quarterly losses of $(8.11 thousand) per share. This is a 58.78 percent decrease over losses of $(5.11 thousand) per share from the same period last year. The company